Últimos Artículos de Diabetes, Obesity and Metabolism
- Efficacy, tolerability, and safety of Efsubaglutide Alfa in participants with obesity or overweight (LIGHT 1): A randomized, double‐blind, placebo‐controlled, ascending‐dose phase 2a trial
- Once‐weekly insulin icodec versus once‐daily insulin degludec for type 2 diabetes in China: A cost‐utility and budget impact analysis
- Effects of age and disease duration on the glycaemic outcomes and safety of insulin glargine 300 U/mL in people with type 2 diabetes in China: A post‐hoc analysis of the INITIATION study
- C‐peptide as an important biomarker in diabetes management: The need for standardization of its measurement
- Dual action of imeglimin on insulin secretion and sensitivity in type 2 diabetes
- Increasing cardiovascular mortality in young adults with diabetes mellitus as a contributing cause in the United States
- Oral semaglutide and survival in heart failure with preserved ejection fraction and type 2 diabetes
- Comparison of DXA, BIA, and anthropometry for assessing subcutaneous, visceral, liver, and pancreas fat measured by MRI
- Associations between anthropometric measures of obesity and prediabetes risk: A dose–response meta‐analysis of cohort studies
- Mental health changes after 4 months of weight loss treatment with the glucagon‐like peptide‐1 analogue liraglutide 3.0 mg
- Targeting gut‐derived NETosis: A paradigm shift in understanding metformin's therapeutic action
- Semaglutide and tirzepatide effects on cardiovascular outcomes in people with overweight or obesity in the real world (STEER)
- If treating obesity with GLP‐1‐based therapies protects the heart, could it also prevent cancer or improve cancer outcomes? The case for randomized trials
- The importance of treatment sequencing with SGLT2 inhibitors and GLP‐1 receptor agonists combination for kidney function preservation in type 2 diabetes
- Age disparities in SGLT2 inhibitor prescription among people with type 2 diabetes: The role of frailty and sex
- Challenges in glycaemic control among women with type 1 diabetes and the role of MiniMed 780G system: A narrative review
- Performance of continuous glucose monitoring systems (CGMs) during commercial flights in T1DM: A within‐subject comparative pilot study
- Precision nutrition in weight loss and neuroendocrine control of people with obesity: The study protocol of a factorial randomised controlled trial (GenON Programme)
- Obstructive sleep apnea is associated with greater MASH and significant fibrosis severity in patients with obesity: A prospective clinicopathological study
- Comparative safety of glucose‐lowering medications on depression in adults with type 2 diabetes